TSR-042

2 stories · following the connections

Business

TESARO Summarizes TSR-042 Clinical Data Presented at AACR

By Nasdaq OMXApr 16, 2018, 1:01 PM UTC

Business

TESARO Initiates Registrational Development Program for Anti-PD-1 Antibody TSR-042

By Nasdaq OMXApr 27, 2017, 12:15 PM UTC